2019 Biotech Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: BulbaMan	9/30/2019 9:55:21 PM
	Read Replies (1) of 280

Q3 2019 Contest update Biotechs had a dismal quarter significantly trimming YTD performance. At Q3’s close, the Contest median was up 1.86% YTD (vs. up 21.91% YTD at Q2's close), the Nasdaq Biotech Index (NBI) was up 2.76% YTD (vs. up 12.63% YTD at Q2's close) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 5.83% YTD (vs. up 21.90% YTD at Q2's close), while the Nasdaq Composite Index (NCI) was up 20.56% YTD (vs. up 20.66% YTD at Q2's close). At Q3's close, BULBA’s portfolio was still in the Contest lead with a 77.91% YTD gain. ANDRE’s portfolio, up 44.00% YTD and ARTHUR’s portfolio, up 38.14% YTD, were in second and third place. At Q3's close, 21 of the 39 Contest portfolios were in the green, while 18 were beating the NBI and 17 were beating the SPSIBI. The 167 Contest stock picks had an average YTD gain of 6.94% and a median YTD loss of -2.20%. Summary tables to follow. Happy New Year! Peace & good health, Bulba

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next